Fact Based List:
Top U.S. Life Science R&D Expenditures for Q1-Q3 2012
Submitted by Anonymous on Thu, 12/20/2012 - 14:20
- Pfizer - $5,734
- Merck & Co. - $5,945
- Johnson & Johnson - $5,334
- Lilly (Eli) & Co. - $3,815
- Abbott Laboratories - $3,181
- Bristol-Myers Squibb Co. - $2,822
- Amgen - $2,411
- Celgene - $1,251
- Medtronic (estimated) - $1,167
- Monsanto - $1,166
Notes: In millions
Source: Battelle/R&D Magazine
Source URL: http://www.battelle.org/docs/default-document-library/2013-R...
List Ratings: |
Lists You Might Also Be Interested In
- Health Insurance Companies Whose Medicare Advantage Contracts Have an Average Star Rating Above 4.5 When Weighted by Enrollment
- Cynthia Hundorfean: Three promising areas for predictive analtyics
- Tina Reed: 3 Ways to Inspire Innovation in Healthcare
- Healthcare Finance: 5 ways Amazon Could Disrupt Healthcare
- Kent Locklear, MD: 5 Elements of Effective Population Health
Login or register to post comments